TOKYO, Dec 18 (Reuters) - Japan’s Shionogi & Co said on Tuesday that it has applied to health regulators in the United States, Canada and Europe for approval of its HIV drug Dolutegravir. Shionogi developed Dolutegravir with a Viiv Healthcare, an AIDS drug joint venture between GlaxoSmithKline and Pfizer, in exchange for its rights to the drug.
There are a lot of drug companies in the United States.
( z1 company :mod ( z2 drug ) :quant ( z3 lot ) :location ( z4 country :name ( z5 name :op "United" :op "States" ) ) )